| Product Code: ETC9690519 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Nucleic Acid-Based Drugs Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Nucleic Acid-Based Drugs Market - Industry Life Cycle |
3.4 Thailand Nucleic Acid-Based Drugs Market - Porter's Five Forces |
3.5 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume Share, By Category, 2021 & 2031F |
3.6 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume Share, By Structure, 2021 & 2031F |
3.7 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume Share, By Target, 2021 & 2031F |
3.8 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume Share, By Mechanism, 2021 & 2031F |
3.9 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Nucleic Acid-Based Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders in Thailand |
4.2.2 Rising demand for personalized medicine and targeted therapies |
4.2.3 Growing investments in research and development of nucleic acid-based drugs |
4.3 Market Restraints |
4.3.1 Stringent regulations and lengthy approval processes for nucleic acid-based drugs |
4.3.2 High cost associated with development and production of nucleic acid-based drugs |
4.3.3 Limited awareness and acceptance of nucleic acid-based drugs among healthcare professionals and patients in Thailand |
5 Thailand Nucleic Acid-Based Drugs Market Trends |
6 Thailand Nucleic Acid-Based Drugs Market, By Types |
6.1 Thailand Nucleic Acid-Based Drugs Market, By Category |
6.1.1 Overview and Analysis |
6.1.2 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Category, 2021- 2031F |
6.1.3 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Antisense, 2021- 2031F |
6.1.4 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By SiRNA, 2021- 2031F |
6.1.5 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By MiRNA, 2021- 2031F |
6.1.6 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Aptamer, 2021- 2031F |
6.1.7 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Decoy, 2021- 2031F |
6.1.8 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By CpG-oilgo, 2021- 2031F |
6.2 Thailand Nucleic Acid-Based Drugs Market, By Structure |
6.2.1 Overview and Analysis |
6.2.2 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Single Stranded DNA/RNA, 2021- 2031F |
6.2.3 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Double Stranded DNA, 2021- 2031F |
6.2.4 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Single-Stranded DNA, 2021- 2031F |
6.2.5 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Nucleic Acid-Based Drugs Market, By Target |
6.3.1 Overview and Analysis |
6.3.2 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Transcriptor Factor, 2021- 2031F |
6.3.3 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By TLR9-Receptor, 2021- 2031F |
6.3.4 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Protein, 2021- 2031F |
6.4 Thailand Nucleic Acid-Based Drugs Market, By Mechanism |
6.4.1 Overview and Analysis |
6.4.2 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Inhibits the Physiological Effect, 2021- 2031F |
6.4.3 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Adjuvant, 2021- 2031F |
6.4.4 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Inhibits Transcription, 2021- 2031F |
6.4.5 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Thailand Nucleic Acid-Based Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Thailand Nucleic Acid-Based Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Thailand Nucleic Acid-Based Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Nucleic Acid-Based Drugs Market Import-Export Trade Statistics |
7.1 Thailand Nucleic Acid-Based Drugs Market Export to Major Countries |
7.2 Thailand Nucleic Acid-Based Drugs Market Imports from Major Countries |
8 Thailand Nucleic Acid-Based Drugs Market Key Performance Indicators |
8.1 Number of clinical trials involving nucleic acid-based drugs in Thailand |
8.2 Adoption rate of nucleic acid-based drugs by healthcare facilities in Thailand |
8.3 Investment in nucleic acid-based drug research and development in Thailand |
9 Thailand Nucleic Acid-Based Drugs Market - Opportunity Assessment |
9.1 Thailand Nucleic Acid-Based Drugs Market Opportunity Assessment, By Category, 2021 & 2031F |
9.2 Thailand Nucleic Acid-Based Drugs Market Opportunity Assessment, By Structure, 2021 & 2031F |
9.3 Thailand Nucleic Acid-Based Drugs Market Opportunity Assessment, By Target, 2021 & 2031F |
9.4 Thailand Nucleic Acid-Based Drugs Market Opportunity Assessment, By Mechanism, 2021 & 2031F |
9.5 Thailand Nucleic Acid-Based Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Thailand Nucleic Acid-Based Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Nucleic Acid-Based Drugs Market - Competitive Landscape |
10.1 Thailand Nucleic Acid-Based Drugs Market Revenue Share, By Companies, 2024 |
10.2 Thailand Nucleic Acid-Based Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here